Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
KILITCH.NS
HoldHot AirKilitch Drugs (India) Limited · Healthcare · India · $69M · Avg Vol: $62K/d
58
StockRankGet insider-trade alerts
Q
48
V
43
M
61
P/E (TTM)
21.4x
ROE
10.8%
D/E
0.3x
Dividend %
—
COMPANY DESCRIPTION
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.4B | 1.5B | 2.0B | 2.4B | 19.2% | 2.4B |
| EPS (INR) | 3.28 | 4.49 | 8.12 | 8.91 | 39.5% | 8.79 |
| Shares | 31.8M | 32.9M | 32.9M | 35.0M | +9.8% | 35.0M |
| Debt | 221.9M | 316.5M | 494.2M | 887.1M | 58.7% | 887.1M |
| Equity | 1.5B | 1.8B | 2.0B | 2.8B | 22.6% | — |
| Op CF | 25.9M | -15.3M | 175.4M | 239.6M | 110.0% | 239.6M |
| Inv CF | 79.2M | -81.6M | -399.5M | -1.0B | — | — |
| Fin CF | -7.2M | 88.1M | 132.4M | 824.5M | — | — |
Loading 1Y...
PRICE (1Y)+1.2%
SMA 50SMA 200
Close
$1.98
RSI (14)
89.0
52W High
$2.31
From 52W High
0.9%
SCORE BREAKDOWN
Quality
48
ROIC
13.1%78.9
ROE
10.8%72.5
GP/Assets
24.5%53.1
Op. Margin
4.1%50.6
FCF/Assets
-16.5%23.9
Piotroski
25.9
Int. Cover
9.0x60.5
D/E Ratio
0.32x39.6
Current Ratio
1.83x35.0
Value
43
P/E (TTM)
21.4x57.1
EV/EBITDA
18.5x37.3
P/FCF
—N/A
P/B
2.4x55.7
P/S
2.8x59.1
Div Yield
—N/A
Momentum
61
52W High %
86%76.9
RS 6M
22%81.6
SMA 50/200
1.07x70.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-13%16.7
Q Growth
-4%34.3
FUNDAMENTALS
Market Cap
$69M
P/E (Forward)
24.6x
Gross Margin
47.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KILITCH.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KILITCH.NS | Kilitch Drugs (India) Limited(you) | $69M | 58 | Hold |
| BAFNAPH.NS | Bafna Pharmaceuticals Limited | $77M | 55 | Hold |
| ZIMLAB.NS | ZIM Laboratories Limited | $73M | 67 | Buy |
| BAJAJHCARE.NS | Bajaj HealthCare Limited | $120M | 59 | Hold |
| THEMISMED.NS | Themis Medicare Limited | $129M | 62 | Hold |
| WANBURY.NS | Wanbury Limited | $91M | 69 | Buy |
| AMRUTANJAN.NS | Amrutanjan Health Care Limited | $153M | 53 | Hold |
| INDOCO.NS | Indoco Remedies Limited | $237M | 57 | Hold |
| VALIANTLAB.NS | Valiant Laboratories Limited | $65M | 83 | Strong Buy |
| AMANTA.NS | Amanta Healthcare Limited | $83M | 81 | Strong Buy |
Peer medians: ROE 11.9% · P/E 42.8x · Gross margin 59.4%